Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hu, Wenwei
NCT05493683: Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer	Recruiting	2	29	RoW	Disitamab vedotin, RC48, Tislelizumab	The First Affiliated Hospital with Nanjing Medical University	Colorectal Neoplasms	07/25	07/25
NCT04689100: Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor	Recruiting	1	259	RoW	JMT101, FOLFIRI(Irinotecan, Leucovorin Calcium, and Fluorouracil); mFOLFOX6((Oxaliplatin, Leucovorin Calcium, and Fluorouracil);, FOLFIRI; mFOLFOX6; Irinotecan;	Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Advanced Solid Tumor	12/21	06/22